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Abstract
Background: Nidation of floating tumour cells initiates peritoneal carcinosis and limits prognosis
of gastro-intestinal tumours. Adhesion of tumour cells to extracellular matrix components is a
pivotal step in developing peritoneal dissemination of intraabdominal malignancies. Since
phospholipids efficaciously prevented peritoneal adhesion formation in numerous animal studies
we investigated their capacity to reduce adhesions of gastric cancer cells to extracellular matrix
components (ECM).
Methods: Human gastric cancer cells (NUGC-4, Japanese Cancer Research Resources Bank,
Tokyo, Japan) were used in this study. Microtiter plates were coated with collagen IV (coll), laminin
(ln) and fibronectin (fn). Non-specific protein binding of the coated wells was blocked by adding 1%
(w/v) BSA (4°C, 12 h) and rinsing the wells with Hepes buffer. 50.000 tumour cells in 100 µl
medium were seeded into each well. Beside the controls, phospholipids were added in
concentrations of 0.05, 0.1, 0.5, 0.75 and 1.0/100 µl medium. After an incubation interval of 30 min,
attached cells were fixed and stained with 0.1% (w/v) crystal violet. The dye was resuspended with
50 µl of 0.2% (v/v) Triton X-100 per well and colour yields were then measured by an ELISA reader
at 590 nm. Optical density (OD) showed a linear relationship to the amount of cells and was
corrected for dying of BSA/polystyrene without cells.
Results: The attachment of gastric cancer cells to collagen IV, laminin, and fibronectin could be
significantly reduced up to 53% by phospholipid concentrations of 0.5 mg/100 µl and higher.
Conclusion: These results, within the scope of additional experimental studies on mice and rats
which showed a significant reduction of peritoneal carcinosis, demonstrated the capacity of
phospholipids in controlling abdominal nidation of tumour cells to ECM components. Lipid
emulsions may be a beneficial adjunct in surgery of gastrointestinal malignancies.
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In the treatment of gastro-intestinal cancer the detection
of free, isolated tumour cells in the peritoneal cavity serve
as a prognostic marker for postoperative survival [1-4].
Since surgery frequently proofs insufficient for tumour
control, numerous additional treatments have been eval-
uated. A pivotal step in developing peritoneal dissemina-
tion seems to be adhesion of tumour cells to mesothelial
cells or extracellular matrix components [5-7]. Experi-
mental studies suggest that peritoneal metastases tend to
occur in areas of injured peritoneum [8]. Cell-matrix
interactions are promoted by transmembrane receptors
with integrins as a major family. Many attempts were
made to inhibit tumour cell attachment by antibodies
against adhesion molecules [9], dextran sulphate [10], or
sodium hyaluronate [11] with different results concerning
tumour adhesion.
Phospholipids, polar phosphoric acid di-esters, are natu-
ral constituents of the abdominal fluid. The substance is
able to form a lubricant layer on the peritoneal surface
[12]. Additionally, integrin function, particularly in con-
trol of cell motility is affected by exogenous addition of
phospholipids (e.g. gangliosides) [13,14]. Intraperitoneal
use of phospholipids (PL) led to a significant decrease of
adhesion formation especially at sites of peritoneal injury
[15,16]. The objective of the underlying in vitro study was
focused on the influence of phospholipids on adhesion of
gastric cancer cells to extracellular matrix components
with broad reactivity to several integrins. Collagen IV (coll
IV), and laminin (ln) are main components of the base-
ment membrane and fibronectin (fn) plays an important
role in wound healing [17,18].
Methods
Tumour cells
The human gastric cancer cell line NUGC-4 was pur-
chased from the Japanese Cancer Research Resources
Bank (Tokyo, Japan). The cells were maintained in mon-
olayers in tissue culture flasks (75 cm2, Falcon, Becton
Dickinson-Gambil, Heidelberg, Germany) in RPMI 1640
medium (GIBCO, Karlsruhe, Germany), supplemented
with 10% foetal bovine serum (GIBCO), penicillin and
streptomycin (GIBCO). Cell cultures were incubated at
37°C in a humidified atmosphere of 5% CO2 in air. Cells
were passaged after treatment with 0.125% trypsin for 6
min. The cells were pelleted after centrifugation for 10
min at 200 g, suspended in 20 ml PBS, and pelleted. The
cell pellet was resuspended in 30 ml complete medium
and seeded with a splitting ratio of 1:3. Only cells from
three passages were used for the experiments.
Extracellular matrix (ECM) components
Flat-bottom polystyrene microtiter plates (Becton Dickin-
son, Heidelberg, Germany) were coated for adhesion
experiments. The purified ECM components were dis-
solved in PBS with the following concentrations: coll IV –
2,5 µg/ml (Biomol, Hamburg, Germany), fn – 10 µg/ml
(Boehringer, Mannheim, Germany), ln – 50 µg/ml (Boe-
hringer, Mannheim, Germany). We found these concen-
trations to be optimal in foregoing dilution series. They
were added to the wells and incubated at 4°C for 24 hours
(coll IV, fn), or at 37°C for 45 min in a humidified atmos-
phere of 5% CO2 in air (ln), respectively. Nonspecific pro-
tein binding of the coated wells was blocked by adding
1% (w/v) BSA (4°C, 12 h) and rinsing the wells with
Hepes buffer.
Adhesion assay
For adhesion experiments gastric cancer cells were
detached with collagenase I (15 min, 37°C, Worthington,
Freehold, USA), washed once with RPMI 1640, centri-
fuged (200 g for 10 min), resuspended in RPMI 1640, and
preincubated for 30 min in a humidified atmosphere of
5% CO2 in air (37°C). Fifty thousand tumour cells in 100
µl medium were seeded into each well. Evaluation of
adherent cells was performed using crystal violet staining
according to the method described by Aumeilley et al.,
and Tietze et al. [19,20]. After an incubation period of 30
min the supernatant with non-adherent cells was
removed by two washes with warmed RPMI 1640.
Attached cells were fixed with 30% (v/v) methanol/etha-
nol for 15 min at room temperature. Cells were stained
with 0.1% (w/v) crystal violet (Sigma, Hamburg, Ger-
many), extensively washed with distilled water, and dried
at room temperature. The dye was resuspended with 50 µl
of 0.2% (v/v) Triton X-100/well and colour yields were
then measured using an ELISA reader at 590 nm (Titertek
Multiscan Plus MKII, Flow Laboratories GmbH, Mecken-
heim, Germany). Optical density (OD) showed a linear
relationship to the amount of cells between 1 × 103 and 5
× 104 cells per well, as determined by a dilution series.
Control dying of BSA/polystyrene without cells led to
Optical Density (OD) values of 0.01–0.07. These values
were subtracted from those obtained in the experiments.
Phospholipids
After complete preparation of the tumour cell suspension,
the PL solution was added in the following concentra-
tions: 0.05, 0.1, 0.5, 0.75, and 1 mg per 100 µl medium.
The concentrations used were correlated to our in vivo
experiments. The phospholipid solution consists of phos-
phatidylcholine 70% by weight, phosphatidyleth-
anolamine 15% by weight, neutral lipids 8% by weight,
sphingomyelin <3% by weight and lysophosphatidylcho-
line <3% by weight.Page 2 of 5
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All experiments were performed three times in quadrupli-
cate. The data are expressed as means +/- standard error of
the mean (SEM). Student's t-test for unpaired data was
used for statistical analysis. Differences were regarded as
significant for p values < 0.05.
Results
The analysis of tumour cell adhesion to BSA 1% resulted
in a mean extinction of 0.27 (SEM 0.01) at 590 nm. Coat-
ing with ln and fn led to a nearly twofold increase of
tumour cell adhesion with mean values of 0.59 (0.03, ln)
and 0.63 (0.03, fn). The cancer cells showed a most pro-
nounced adhesion to coll IV with a mean extinction of
0.97 (0.02).
The tumour cell adhesion to ln registered after addition of
PL was significantly reduced. The effect was concentration
dependent compared to the controls. Even the minimum
amount of PL 0.05 mg/100 µl led to a reduced extinction
of 0.4 (0.01). Treatment with 0.1 or 0.5 mg/100 µl PL
revealed extinction values of 0.32 (0.02) and 0.28 (0.02),
respectively. The maximum effect could be demonstrated
with 0.75 mg/100 µl PL with an extinction of 0.24 (0.02).
The relative reduction of tumour cell adhesion compared
to the control amounts to 59%. Treatment with 1 mg/100
µl PL showed no further decrease of tumour cell adhesion
to ln. The mean extinction was 0.26 (0.01) (table 1).
The tumour cell adhesion on fn could not be reduced sig-
nificantly with low concentrations of Pl. Addition of 0.05
mg/100 µl PL and 0.1 mg/100 µl resulted in a slight reduc-
tion of the extinction with mean values of 0.59 (0.02) and
0.59 (0.01). However, a significant reduction of tumour
cell adhesion could be observed after treatment with 0.5
mg/100 µl PL, 0.42 (0.02); as well as with 0.75 mg/100 µl
PL (0.39 (0.02)) and 1 mg/100 µl PL (0.38 (0.02)). We
found a similar situation compared to ln with equal
effects of 0.75 mg/100 µl and 1 mg/100 µl PL indicating
that the maximum influence on adhesion is reached. The
relative reduction of tumour cell adhesion compared to
the control values amounts to 40% (table 2).
NUGC-4 gastric cancer cells prominently adhere to colla-
gen IV compared to all other examined extracellular
matrix components. The influence of PL on cell adhesion
to coll IV was also concentration dependent. The reduc-
tion ranged from an extinction of 0.89 (0.01) after admin-
istration of 0.05 mg/100 µl PL to a maximum effect after
treatment with 1 mg/100 µl PL with a value of 0.44 (0.02)
(table 3). In comparison to the control value, this means
a reduction of adherent tumour cells of 55%.
Discussion
Cell adhesion to the extracellular matrix plays a funda-
mental role in peritoneal carcinosis. The adhesion is
mediated by transmembrane Integrins. Several proteins
including fibronectin in the interstitial matrix, laminin
and collagen IV in the basement membrane were identi-
fied as important ligands [21,22]. Many attempts were
made to inhibit tumour cell adhesion by integrin antibod-
ies or competitive inhibitors against specific peptide
sequences [23-26]. Gui et al. showed that adhesion of dif-
ferent breast cancer cells to extracellular matrix compo-
Table 1: Influence of different phospholipid concentrations on 
adhesion of gastric cancer cells to laminin. Optical density (OD) 





PL 0.05 mg/well 0.4 0.01 p < 0.05
PL 0.1 mg/well 0.32 0.02 p < 0.05
PL 0.5 mg/well 0.28 0.02 p < 0.05
PL 0.75 mg/well 0.24 0.02 p < 0.05
PL 1 mg/well 0.26 0.01 p < 0.05
Table 2: Influence of different phospholipid concentrations on 
adhesion of gastric cancer cells to fibronectin. Optical density 





PL 0.05 mg/well 0.59 0.02 n. s.
PL 0.1 mg/well 0.59 0.01 n. s.
PL 0.5 mg/well 0.42 0.02 p < 0.05
PL 0.75 mg/well 0.39 0.02 p < 0.05
PL 1 mg/well 0.38 0.02 p < 0.05
Table 3: Influence of different phospholipid concentrations on 
adhesion of gastric cancer cells to collagen IV. Optical density 





PL 0.05 mg/well 0.9 0.01 p < 0.05
PL 0.1 mg/well 0.74 0.02 p < 0.05
PL 0.5 mg/well 0.61 0.02 p < 0.05
PL 0.75 mg/well 0.45 0.03 p < 0.05
PL 1 mg/well 0.44 0.02 p < 0.05Page 3 of 5
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[27]. However, different antibodies for different cell lines
were necessary according to the expression of specific
integrins on the cell surface. Haier et al. could find differ-
ent adhesive capacities to collagen I in two subtypes of the
HT-29 colon carcinoma cell line. The cells with a very lim-
ited capability to induce hepatic metastases showed a sig-
nificant higher rate of adhesions compared to those
inheriting a high potential for involvement of the liver
[28]. The influence of three examined phosphotyrosine
kinase inhibitors on integrin mediated tumour cell adhe-
sion to collagen I was unspecific. Dennis et al. found dif-
ferent cell-surface receptors responsible for cell
attachment to fibronectin and collagen as compared to
laminin. They concluded with the hypothesis that specific
glycolipids may be receptors for interaction with fibronec-
tin [29].
In our experiments the reduced rate of cell attachment in
the presence of phospholipids was independent from the
extracellular matrix. A similar effect on intraperitoneal
tumour growth was described by Jacobi et al. who could
demonstrate that taurolidine/heparin and povidone
iodine lead to a significant reduction of tumour cell
growth in vitro as well as a reduction of tumour weight
after intraperitoneal tumour injection [30]. Predomi-
nantly the result seems to be a attributed to the cytotoxic
effect of the used substances and benefits to a lesser degree
from adhesion prevention. Other substances used to pre-
vent adhesion failed in the treatment of inhibiting tumour
cell attachment. Sodium hyalunorate increased the meta-
static potential of colo-rectal tumour cells, probably medi-
ated by the CD44 receptor [31]. Dextran sulphate resulted
in reduced tumour cell nidation at sites of injury to
abdominal wall in mice [10,32]. However, several side
effects were described in the use of dextrane for adhesion
prevention. Main problems were oedema, pleura effusion,
life-threatening coagulation disorders and severe allergic
reactions [33,34]. Phospholipids, polar phosphoric acid
di-esters, are natural constituents of the abdominal cavity
fluid and cell membranes.
The hypothesis is that phospholipids form a lubricant
layer on the peritoneum by binding with its negatively
charged cholin branch chain to the positively charged
peritoneal surface [12,14,35]. Phospholipids cover the
entire peritoneal membrane by a thin fluid layer. By sepa-
rating tumour cells from the peritoneal surface they
proved to significantly reduce peritoneal carcinosis. Phos-
pholipipds seem to reduce the expression of integrins and
adhesion molecules on the cell surface to the effect that
adhesions can be prevented reducing tumour cell attach-
ment independent from their origin [15,16].
The in situ tumour cell – ECM interaction is influenced by
adhesive and non-adhesive ECM components and can be
understood as a three dimensional network [36]. There-
fore the in vitro experiments with tumour cells as soluble
agents added to ECM immobilized onto plastic surfaces
cannot appropriately mimic the situation in situ. Recently
we found that phospholipids significantly reduce the
attachment area and the tumour volume of peritoneal car-
cinosis caused by the colonic cancer cell line DHD/K12/
TRb in rats. These results were supported by a prolonged
survival rate of the treated animals as compared to the
control group. Additionally, we found a similar effect of
phospholipids on the adhesion of the human rectal can-
cer cell line HRT-18 on the same ECM-components in vitro
[37]. Consistent with results of other groups, the tumour
cell attachment was found predominantly in areas of pre-
viously injured peritoneum [5,6,38,39].
We performed this study to ascertain the results of the
foregoing animal experiments and to demonstrate the
influence of phospholipids to three different ECM com-
ponents, even though matrices of collagen IV, laminin
and fibronectin alone may not be predictive of peritoneal
membrane nidation.
Conclusion
These results, within the scope of additional experimental
studies on mice and rats which showed a significant
reduction of peritoneal carcinosis, demonstrated the
capacity of phospholipids in controlling abdominal nida-
tion of tumor cells to ECM components. Lipid emulsions
may be a beneficial adjunct in surgery of gastrointestinal
malignancies.
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